In this study, human PBMCs were primed with either Gemini or placebo followed by challenge with clinically relevant promoter molecules of inflammation including high mobility box protein-1 (HMGB-1) ...
This article is based on a poster originally authored by Diana Chiluiza, Ph.D., Immune Cell Isolation Manager at BioIVT and Courtney Noah, Ph.D., Vice President of Scientific Affairs at BioIVT. Human ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results